Skip to main content

Discogenic Pain

3
Pipeline Programs
6
Companies
7
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
2
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Spine BioPharma
Spine BioPharmaNY - New York
2 programs
1
Functional anesthetic discographyPhase 4
Bone Marrow ConcentrateN/A1 trial
Active Trials
NCT03340818Completed66Est. Aug 2024
Medtronic
MedtronicNJ - Phillipsburg
1 program
1
Functional anesthetic discographyPhase 41 trial
Active Trials
NCT01077947Withdrawn0Est. Feb 2014
Stayble Therapeutics
Stayble TherapeuticsSweden - Gothenburg
1 program
1
STA363 containing 90 mgPhase 21 trial
Active Trials
NCT04673461Completed110Est. Oct 2023
Vivex Biologics
Vivex BiologicsGA - Atlanta
2 programs
VIA Disc NPN/A1 trial
VIA Disc NPN/A1 trial
Active Trials
NCT04652687Terminated83Est. Mar 2024
NCT06345690Recruiting500Est. Jan 2027
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
High yield pure PRPN/A1 trial
Active Trials
NCT04064866Completed27Est. Feb 2019
Abbott
AbbottABBOTT PARK, IL
1 program
NeurostimulationN/A1 trial
Active Trials
NCT03958604Completed16Est. Dec 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
MedtronicFunctional anesthetic discography
Stayble TherapeuticsSTA363 containing 90 mg
Vivex BiologicsVIA Disc NP
Vivex BiologicsVIA Disc NP
AbbottNeurostimulation
Spine BioPharmaBone Marrow Concentrate
Angeles TherapeuticsHigh yield pure PRP

Clinical Trials (7)

Total enrollment: 802 patients across 7 trials

NCT01077947MedtronicFunctional anesthetic discography

Value of Functional Anesthetic and Provocative Discography in the Surgical Treatment of Discogenic Pain

Start: Feb 2010Est. completion: Feb 20140
Phase 4Withdrawn
NCT04673461Stayble TherapeuticsSTA363 containing 90 mg

Study Investigating STA363 Compared to Placebo in Patients With Chronic Discogenic Low Back Pain

Start: Jul 2020Est. completion: Oct 2023110 patients
Phase 2Completed
NCT06345690Vivex BiologicsVIA Disc NP

VIA Disc NP Registry 3.0

Start: Feb 2024Est. completion: Jan 2027500 patients
N/ARecruiting
NCT04652687Vivex BiologicsVIA Disc NP

VIA Disc NP Registry

Start: May 2020Est. completion: Mar 202483 patients
N/ATerminated
NCT03958604AbbottNeurostimulation

Burst Neurostimulation for Discogenic Low Back Pain

Start: May 2019Est. completion: Dec 202116 patients
N/ACompleted
NCT03340818Spine BioPharmaBone Marrow Concentrate

Bone Marrow Concentrate Intradiscal Injection for Chronic Discogenic Low Back Pain

Start: Aug 2018Est. completion: Aug 202466 patients
N/ACompleted
NCT04064866Angeles TherapeuticsHigh yield pure PRP

Safety and Efficacy of PRP for Treatment of Disc Pain

Start: May 2016Est. completion: Feb 201927 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 802 patients
6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.